Eagle Global Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,170
Closed -$341K 393
2016
Q3
$341K Sell
17,170
-22,393
-57% -$391K 0.01% 252
2016
Q2
$565K Hold
39,563
0.02% 186
2016
Q1
$614K Hold
39,563
0.02% 178
2015
Q4
$682K Hold
39,563
0.02% 167
2015
Q3
$482K Buy
39,563
+18,813
+91% +$241K 0.02% 210
2015
Q2
$250K Buy
+20,750
New +$204K 0.01% 304

Other funds holding LMAT

Eagle Global Advisors's LMAT Position: Q4 2016 in Review

Eagle Global Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2016, closing a stake of 17,170 shares — an estimated $341K sold.

Eagle Global Advisors first reported a position in LMAT in Q2 2015 and held it in 6 quarters. The position peaked at $682K in Q4 2015. 112 funds tracked by Wall St. Rank hold LMAT as of Q4 2016.

  • Eagle Global Advisors reported no remaining LeMaitre Vascular position as of Q4 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 17,170 LeMaitre Vascular shares in Q4 2016, an estimated $341K.
  • Eagle Global Advisors first reported a position in LeMaitre Vascular in Q2 2015 and held it in 6 quarters.
  • Eagle Global Advisors's LeMaitre Vascular position peaked at $682K in Q4 2015.
  • 112 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2016.

Based on Eagle Global Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.